View Author
dai: 171662962
scopus: 7003686610
Boer, M.L. den
(Monique den Boer)Supervisor (promotor) of 1 dissertation
expression patient leukemia mirna level lymphoblastic leukemia study protein sample infant lymphoblastic blood analysis medulloblastoma figure group cancer children resistance ependymoma table treatment tumor childhood mutation novel number probe factor signi subtype outcome sensitivity receptor rearrangement survival mll-rearranged value microrna target leukemic precursor sequence myeloid leukemia prognostic result igfbp control response apoptosi leukemic cells prednisolone flt 3 l-asparaginase signi ficantly score vegfc b-all glucocorticoid fication drug resistance gene expression mir -128b myeloid overexpression erasmu kinase cmc -544 mll-af activation probe sets diagnosis growth den boer ml pieter fusion tel-aml cohort erasmus mc pieters r
10 Most Recent Publications
|
The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells
(Article)
Vries, J.F. de Zwaan, C.M. Bie, M. de Voerman, J.S. Boer, M.L. den Dongen, J.J.M. van Velden, V.H.J. van der |
2012-02-01
|
|
Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia
(Article)
Schotte, D. Moqadam, F.A. Lange-Turenhout, E.A.M. Chen, C. IJcken, W.F.J. van Pieters, R. Boer, M.L. den |
2011-09-01
|
|
MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
(Article)
Lerner, M. Lundgren, J. Sangfelt, O. Akhoondi, S. Jahn, A. Ng, H.-F. Moqadam, F.A. Oude Vrielink, J.A.F. Agami, R. Boer, M.L. den Grandér, D. |
2011-07-01
|
|
MicroRNAs in acute leukemia: from biological players to clinical contributors
(Article)
Schotte, D. Pieters, R. Boer, M.L. den |
2011-06-24
|
|
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)
(Article)
Escherich, G. Tröger, A. Pieters, R. Boer, M.L. den Horstmann, M. Janka, G.E. Göbel, U. Graubner, U. Pekrun, A. Jorch, N. Kaspers, G.J.J.L. Zimmermann, M. Stadt, U.Z. Kazemier, K.M. |
2011-06-01
|
|
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia
(Article)
Schotte, D. Menezes, R.X. de Moqadam, F.A. Khankahdani, L.M. Lange-Turenhout, E.A.M. Chen, C. Pieters, R. Boer, M.L. den |
2011-05-01
|
|
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
(Article)
Balgobind, B.V. Heuvel-Eibrink, M.M. van den Cayuela, J.M. Baruchel, A. Meyer, C. Marschalek, R. Trka, J. Stary, J. Beverloo, H.B. Pieters, R. Zwaan, C.M. Boer, M.L. den Menezes, R.X. de Reinhardt, D. Hollink, I.H.I.M. Arentsen-Peters, S.T.C.J.M. Wering, E.R. van Kaspers, G.J. Cloos, J. Bont, E.S.J.M. de |
2011-02-01
|
|
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)
(Article)
Kuipers, J.E. Coenen, E.A. Danen-van Oorschot, A.A. Boer, M.L. den Marschalek, R. Meyer, C. Pieters, R. Zwaan, C.M. Heuvel-Eibrink, M.M. van den Balgobind, B.V. Stary, J. Baruchel, A. Haas, V. de Bont, E.S.J.M. de Reinhardt, D. Kaspers, G.J. Cloos, J. |
2011-01-20
|
|
Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale
(Article)
Stumpel, D.J.P.M. Schotte, D. Lange-Turenhout, E.A.M. Schneider, P. Seslija, L. Menezes, R.X. de Marquez, V.E. Pieters, R. Boer, M.L. den Stam, R.W. |
2010-11-30
|
|
High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia
(Article)
Jonge, H.J.M. de Valk, P.J.M. Kamps, W.A. Löwenberg, B. Bont, E.S.J.M. de Veeger, N.J.G.M. Elst, A. ter Boer, M.L. den Cloos, J. Haas, V. de Heuvel-Eibrink, M.M. van den Kaspers, G.J. Zwaan, C.M. |
2010-09-09
|
